| Jun 5 |
Should You Buy the 3 Highest-Yielding Dividend Stocks in the Nasdaq-100?
|
| Jun 5 |
Gilead Sciences: Preserving Fertility in the Face of a Cancer Diagnosis
|
| Jun 5 |
Lilly details MASH data for tirzepatide; Cytokinetics comments on past sale talks
|
| Jun 5 |
The Dividend Dynamos: 7 Stocks That Will Energize Your Income Stream
|
| Jun 5 |
7 Dividend Stocks to Invest In for a Lifetime of Income
|
| Jun 5 |
Gilead progresses subject enrolment in HIV prevention trials
|
| Jun 5 |
J&J seeks expanded approvals for paediatric HIV-1 therapy
|
| Jun 5 |
Gilead’s Seladelpar Demonstrated a Sustained and Consistent Long-Term Efficacy and Safety Profile in Primary Biliary Cholangitis
|
| Jun 4 |
National Institutes of Health Kickstarts Gilead Sponsored Trials For Twice-Yearly HIV Prevention Injection
|
| Jun 4 |
Sector Update: Health Care Stocks Rise Tuesday Afternoon
|
